Trial Profile
Thymoglobulin: Presence and Affect in the Central Lymphatic Compartment.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Jun 2018
Price :
$35
*
At a glance
- Drugs Antithymocyte globulin (Primary)
- Indications Renal transplant rejection
- Focus Pharmacodynamics
- 05 Mar 2010 Actual number of patients (3) added as reported by ClinicalTrials.gov record.
- 05 Mar 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Feb 2009 Planned end date changed from 1 Feb 2009 to 1 Dec 2009 as reported by ClinicalTrials.gov.